21,800 Shares in iSpecimen Inc. (NASDAQ:ISPC) Purchased by Bridgeway Capital Management LLC

Bridgeway Capital Management LLC purchased a new position in shares of iSpecimen Inc. (NASDAQ:ISPC) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 21,800 shares of the company’s stock, valued at approximately $58,000.

iSpecimen Stock Up 0.9%

NASDAQ ISPC opened at $1.18 on Wednesday. iSpecimen Inc. has a 52-week low of $1.02 and a 52-week high of $11.80. The business’s 50-day moving average price is $1.26 and its 200 day moving average price is $2.42. The firm has a market cap of $2.95 million, a P/E ratio of -0.06 and a beta of 1.73.

iSpecimen (NASDAQ:ISPC) last announced its quarterly earnings data on Monday, April 14th. The company reported ($6.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($4.00) by ($2.28). iSpecimen had a negative net margin of 91.66% and a negative return on equity of 139.25%. The business had revenue of $1.48 million during the quarter, compared to analysts’ expectations of $2.98 million.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.